Drug and Alcohol Review
ISSN 0959-5236 · Wiley · United States · active 1964–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Drug and Alcohol Review a predatory journal?
Our screening does not flag Drug and Alcohol Review. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Drug and Alcohol Review indexed in Scopus or Web of Science?
Per our venue index, Drug and Alcohol Review appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Drug and Alcohol Review's impact?
Papers in Drug and Alcohol Review are cited about 2.2 times each within two years of publication, and Scimago places it in Q1, with an h-index of 111. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Drug and Alcohol Review open access?
We hold no reliable open-access classification for Drug and Alcohol Review. Check the journal's own site for its access model and any article processing charge.
Similar venues
- Environmental Science & Technology LettersQ1 · American Chemical Society
- Harm Reduction JournalQ1 · BioMed Central
- AddictionQ1 · Wiley
- International Journal of Drug PolicyQ1 · Elsevier BV
- Addictive BehaviorsQ1 · Elsevier BV
- International Journal of Mental Health and AddictionQ2 · Springer Science+Business Media